Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

37 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Spatial intra-tumour heterogeneity and treatment-induced genomic evolution in oesophageal adenocarcinoma: implications for prognosis and therapy.
Brosda S, Aoude LG, Bonazzi VF, Patel K, Lonie JM, Belle CJ, Newell F, Koufariotis LT, Addala V, Naeini MM; AGITG DOCTOR Investigators; Pearson JV, Krause L, Waddell N, Barbour AP. Brosda S, et al. Among authors: aoude lg. Genome Med. 2024 Jul 17;16(1):90. doi: 10.1186/s13073-024-01362-z. Genome Med. 2024. PMID: 39020404 Free PMC article.
POT1 and multiple primary melanomas: the dermatological phenotype.
Maas EJ, DeBortoli E, Nathan V, Freeman NP, Mothershaw A, Smit DJ, Betz-Stablein B, Aoude LG, Stark MS, Sturm RA, Soyer HP, McInerney-Leo AM. Maas EJ, et al. Among authors: aoude lg. J Med Genet. 2024 Aug 29;61(9):891-894. doi: 10.1136/jmg-2023-109637. J Med Genet. 2024. PMID: 38724174
The oesophageal adenocarcinoma tumour immune microenvironment dictates outcomes with different modalities of neoadjuvant therapy - results from the AGITG DOCTOR trial and the cancer evolution biobank.
Lonie JM, Brosda S, Bonazzi VF, Aoude LG, Patel K, Brown I, Sharma S, Lampe G, Addala V, Koufariotis LT, Wood S, Waddell N, Dolcetti R, Barbour AP. Lonie JM, et al. Among authors: aoude lg. Front Immunol. 2023 Oct 12;14:1220129. doi: 10.3389/fimmu.2023.1220129. eCollection 2023. Front Immunol. 2023. PMID: 37965317 Free PMC article.
GOLM1: expanding our understanding of melanoma susceptibility.
Maas EJ, Wallingford CK, DeBortoli E, Smit DJ, Betz-Stablein B, Aoude LG, Stark MS, Sturm RA, Soyer HP, McInerney-Leo AM. Maas EJ, et al. Among authors: aoude lg. J Med Genet. 2023 Sep;60(9):835-837. doi: 10.1136/jmg-2023-109348. Epub 2023 Jul 24. J Med Genet. 2023. PMID: 37487699 No abstract available.
C-reactive protein is a prognostic biomarker in pancreatic ductal adenocarcinoma patients.
Bonazzi VF, Aoude LG, Brosda S, Bradford JJ, Lonie JM, Loffler KA, Gartside MG, Patel K, Mukhopadhyay P, Keane C, Gebski V, Kench JG, Goldstein D, Waddell N, Barbour AP; Australasian Gastro-Intestinal Trials Group (AGITG) GAP investigators. Bonazzi VF, et al. Among authors: aoude lg. Asia Pac J Clin Oncol. 2023 Jul 6. doi: 10.1111/ajco.13993. Online ahead of print. Asia Pac J Clin Oncol. 2023. PMID: 37415393
Multi-omic features of oesophageal adenocarcinoma in patients treated with preoperative neoadjuvant therapy.
M Naeini M, Newell F, Aoude LG, Bonazzi VF, Patel K, Lampe G, Koufariotis LT, Lakis V, Addala V, Kondrashova O, Johnston RL, Sharma S, Brosda S, Holmes O, Leonard C, Wood S, Xu Q, Thomas J, Walpole E, Tao Mai G, Ackland SP, Martin J, Burge M, Finch R, Karapetis CS, Shannon J, Nott L, Bohmer R, Wilson K, Barnes E, Zalcberg JR, Mark Smithers B, Simes J, Price T, Gebski V, Nones K, Watson DI, Pearson JV, Barbour AP, Waddell N. M Naeini M, et al. Among authors: aoude lg. Nat Commun. 2023 May 31;14(1):3155. doi: 10.1038/s41467-023-38891-x. Nat Commun. 2023. PMID: 37258531 Free PMC article.
Comparison of actionable events detected in cancer genomes by whole-genome sequencing, in silico whole-exome and mutation panels.
Ramarao-Milne P, Kondrashova O, Patch AM, Nones K, Koufariotis LT, Newell F, Addala V, Lakis V, Holmes O, Leonard C, Wood S, Xu Q, Mukhopadhyay P, Naeini MM, Steinfort D, Williamson JP, Bint M, Pahoff C, Nguyen PT, Twaddell S, Arnold D, Grainge C, Basirzadeh F, Fielding D, Dalley AJ, Chittoory H, Simpson PT, Aoude LG, Bonazzi VF, Patel K, Barbour AP, Fennell DA, Robinson BW, Creaney J, Hollway G, Pearson JV, Waddell N. Ramarao-Milne P, et al. Among authors: aoude lg. ESMO Open. 2022 Aug;7(4):100540. doi: 10.1016/j.esmoop.2022.100540. Epub 2022 Jul 15. ESMO Open. 2022. PMID: 35849877 Free PMC article.
Unusual suspects in hereditary melanoma: POT1, POLE, BAP1.
Maas EJ, Betz-Stablein B, Aoude LG, Soyer HP, McInerney-Leo AM. Maas EJ, et al. Among authors: aoude lg. Trends Genet. 2022 Dec;38(12):1204-1207. doi: 10.1016/j.tig.2022.06.007. Epub 2022 Jul 7. Trends Genet. 2022. PMID: 35811174
37 results